13F

Stock

Abvc Biopharma, Inc.

ABVC · held by 13 managers

Reported value

$792.1K

Holders

13

+4 new · −6 exited

Holders’ est. mark

−$538K

Price effect on 7 books still in the name

Largest holder

$214.6K

GEODE CAPITAL MANAGEMENT, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC221.2K$214.6K−$234.8KCut−$216.5K
VANGUARD CAPITAL MANAGEMENT LLC190.6K$184.9KHeld
VANGUARD FIDUCIARY TRUST CO97.4K$94.4KHeld
Renaissance Technologies95.1K$92.3K−$110.3KCut−$151.1K
State Street72.8K$70.6K−$84.4KCut−$84.4K
BlackRock, Inc.56.4K$54.8K−$65.5KCut−$65.5K
NORTHERN TRUST CORP32.1K$31.1K−$37.2KCut−$37.2K
TWO SIGMA SECURITIES, LLC21K$20.4KNew
DIMENSIONAL FUND ADVISORS LP12.2K$11.9KNew
Squarepoint Ops LLC10.5K$10.2KNew
Tower Research Capital LLC (TRC)5.42K$5.26K−$3.7KCut−$1.54K
UBS Group AG1.77K$1.72K−$2.05KCut−$3.79K
ROYAL BANK OF CANADA17$0New

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.